GlassScriptPhysician profile
Lindsey Foran
NPI 1033608419
$3,534.68
in general payments reported to CMS, 2019-2025
15 companies · $1,438 in 2025
The $1,438 reported for 2025 was more than what 78% of Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $445).
See the full distribution for Plastic and Reconstructive Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $749 · 2024: $1,347 · 2025: $1,438.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,535.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,534.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $627.12 | 2023-2025 | |
| Integra Lifesciences Corporation | $461.11 | 2023-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Biotissue Holdings INC. | $455.22 | 2024 | |
| Axogen | $328.02 | 2023-2025 | Avance Nerve Graft |
| Polynovo North America LLC | $279.05 | 2024-2025 | Novosorb Btm |
| Stryker Corporation | $271.83 | 2024-2025 | Vsp System, Vsp Cranial, 1788 |
| Solventum Corporation | $239.98 | 2024-2025 | V.A.C. Veraflo, Prevena Restor Bellaform, V.A.C. Veraflo Cleanse Choice |
| Musculoskeletal Transplant Foundation INC. | $183.14 | 2024 | |
| Avita Medical Americas, LLC | $169.10 | 2025 | Recell, Cohealyx, Permeaderm |
| Endo USA, INC. | $133.35 | 2025 | Xiaflex |
| Endo Pharmaceuticals INC. | $124.99 | 2023 | Xiaflex |
| Rti Surgical, INC | $123.53 | 2024 | |
| Motiva USA, LLC | $65.23 | 2025 | |
| Revance Therapeutics, INC. | $57.85 | 2025 | Daxxify |
| Davol INC. | $15.16 | 2023 | Phasix Mesh |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lindsey Foran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.